Page last updated: 2024-08-24

etofibrate and Arteriosclerosis

etofibrate has been researched along with Arteriosclerosis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's4 (36.36)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santafé Oroz, J; Segarra Domènech, J1
Díaz Méndez, M; Priego, JG1
Degenring, FH; Hotz, W; Schatton, W1
Göhmann, E; Mertz, DP; Suermann, I1
Benadé, AJ; Fincham, JE; Quack, G; Wülfroth, P1
Sinzinger, H1
Chelstowski, K; Jastrzebska, M; Kopciewicz, J; Naruszewicz, M; Pieczul-Mróz, J; Torbus-Lisiecka, B1
Fenselau, S; Schrezenmeir, J; Steinmetz, A1
Betz, E; Quack, G1
Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM1
Betz, E; Hämmerle, H1

Reviews

3 review(s) available for etofibrate and Arteriosclerosis

ArticleYear
[Pharmacologic therapy of atherosclerosis (I). Current possibilities].
    Medicina clinica, 1983, Nov-26, Volume: 81, Issue:17

    Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol

1983
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
    Deutsche medizinische Wochenschrift (1946), 1998, Sep-18, Volume: 123, Issue:38

    Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis

1998
Treatment of dyslipoproteinemia in the metabolic syndrome.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4

    Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome

2001

Trials

1 trial(s) available for etofibrate and Arteriosclerosis

ArticleYear
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
    International journal of clinical pharmacology research, 1999, Volume: 19, Issue:1

    Topics: Arteriosclerosis; Clofibric Acid; Diabetes Mellitus, Type 1; Factor VII; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Statistics, Nonparametric

1999

Other Studies

7 other study(ies) available for etofibrate and Arteriosclerosis

ArticleYear
[Pharmacologic therapy of arteriosclerosis: current possibilities].
    Medicina clinica, 1984, Oct-06, Volume: 83, Issue:10

    Topics: Anticholesteremic Agents; Arteriosclerosis; Clofibrate; Clofibric Acid; Humans

1984
[Atherosclerosis treatment with etofibrate retard. New perspectives].
    Fortschritte der Medizin, 1983, Aug-11, Volume: 101, Issue:30

    Topics: Arteriosclerosis; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid

1983
[Etofibrate lowers the atherosclerosis index].
    Medizinische Klinik, 1981, Mar-13, Volume: 76, Issue:6

    Topics: Arteriosclerosis; Clofibrate; Clofibric Acid; Humans; Lipids

1981
Confirmation of efficacy of etofibrate against peripheral atherosclerosis in non-human primates which model human lesion types I-VII.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:5

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Chlorocebus aethiops; Clofibric Acid; Coronary Vessels; Diet, Atherogenic; Eating; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Organ Size

1996
Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis.
    VASA. Zeitschrift fur Gefasskrankheiten, 1990, Volume: 19, Issue:2

    Topics: Animals; Arteriosclerosis; Clofibrate; Clofibric Acid; Disease Models, Animal; Hypolipidemic Agents; Rabbits

1990
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes.
    Immunopharmacology, 1985, Volume: 9, Issue:2

    Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Niacin; Thiophenes; Ticlopidine

1985
Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:1

    Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Carotid Arteries; Cell Division; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Clofibrate; Clofibric Acid; Clone Cells; Electric Stimulation; Fibroblasts; Lipoproteins, HDL; Male; Muscle, Smooth, Vascular; Rabbits; Triglycerides

1986